DMAA

Drugs Made In America Acquisition Corp.

Contracts

Total Value

Stock Metrics

0.0%

Short % Float

5.1d to cover · Moderate squeeze

86.0%

Inst % Float

10 holders · 2026-06-30

Karpus Management,

Top Holder

10.4% of float

65/100

Dilution Score

High

0 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

65/100

HIGH

Inst: 85.95% · Top: Karpus Management, Inc.

Biotech Analytics

Biotech / Pharma

11.65

Dilution Risk: HIGHSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk65

Clinical Trials0

Short Interest10